A detailed history of Cwm, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 14,129 shares of ADMA stock, worth $252,767. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,129
Previous 8,192 72.47%
Holding current value
$252,767
Previous $92,000 206.52%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$11.21 - $20.03 $66,553 - $118,918
5,937 Added 72.47%
14,129 $282,000
Q2 2024

Jul 09, 2024

BUY
$5.98 - $11.18 $26,114 - $48,823
4,367 Added 114.17%
8,192 $92,000
Q1 2024

Apr 05, 2024

BUY
$4.4 - $6.74 $15,782 - $24,176
3,587 Added 1507.14%
3,825 $25,000
Q4 2023

Feb 01, 2024

SELL
$3.08 - $4.52 $36 - $54
-12 Reduced 4.8%
238 $1,000
Q3 2023

Oct 11, 2023

BUY
$3.47 - $4.61 $41 - $55
12 Added 5.04%
250 $1,000
Q4 2022

Feb 01, 2023

BUY
$2.47 - $3.88 $587 - $923
238 New
238 $1,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.51B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.